Upgrade to SI Premium - Free Trial

Boston Scientific (BSX) PT Raised to $29 at Needham & Company Following 4Q Report

February 2, 2017 3:33 PM
Needham & Company raised its price target on Boston Scientific (NYSE: BSX) to $29.00 (from $28.00) while maintaining a Buy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles